Literature DB >> 23721150

Integral dose delivered to normal brain with conventional intensity-modulated radiotherapy (IMRT) and helical tomotherapy IMRT during partial brain radiotherapy for high-grade gliomas with and without selective sparing of the hippocampus, limbic circuit and neural stem cell compartment.

James C Marsh1, G Ellis Ziel, Aidnag Z Diaz, Julie A Wendt, Rohit Gobole, Julius V Turian.   

Abstract

INTRODUCTION: We compared integral dose with uninvolved brain (IDbrain ) during partial brain radiotherapy (PBRT) for high-grade glioma patients using helical tomotherapy (HT) and seven field traditional inverse-planned intensity-modulated radiotherapy (IMRT) with and without selective sparing (SPA) of contralateral hippocampus, neural stem cell compartment (NSC) and limbic circuit.
METHODS: We prepared four PBRT treatment plans for four patients with high-grade gliomas (60 Gy in 30 fractions delivered to planning treatment volume (PTV60Gy)). For all plans, a structure denoted 'uninvolved brain' was created, which included all brain tissue not part of PTV or standard (STD) organs at risk (OAR). No dosimetric constraints were included for uninvolved brain. Selective SPA plans were prepared with IMRT and HT; contralateral hippocampus, NSC and limbic circuit were contoured; and dosimetric constraints were entered for these structures without compromising dose to PTV or STD OAR. We compared V100 and D95 for PTV46Gy and PTV60Gy, and IDbrain for all plans.
RESULTS: There were no significant differences in V100 and D95 for PTV46Gy and PTV60Gy. IDbrain was lower in traditional IMRT versus HT plans for STD and SPA plans (mean IDbrain 23.64 Gy vs. 28 Gy and 18.7 Gy vs. 24.5 Gy, respectively) and in SPA versus STD plans both with IMRT and HT (18.7 Gy vs. 23.64 Gy and 24.5 Gy vs. 28 Gy, respectively).
CONCLUSIONS: In the setting of PBRT for high-grade gliomas, IMRT reduces IDbrain compared with HT with or without selective SPA of contralateral hippocampus, limbic circuit and NSC, and the use of selective SPA reduces IDbrain compared with STD PBRT delivered with either traditional IMRT or HT.
© 2013 The Authors. Journal of Medical Imaging and Radiation Oncology © 2013 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Mesh:

Year:  2013        PMID: 23721150     DOI: 10.1111/1754-9485.12048

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  12 in total

1.  Inclined head position improves dose distribution during hippocampal-sparing whole brain radiotherapy using VMAT.

Authors:  Kyung Su Kim; Suk-Jin Seo; Jaegi Lee; Jin-Yong Seok; Joo Wan Hong; Jin-Beom Chung; Eunji Kim; Noorie Choi; Keun-Yong Eom; Jae-Sung Kim; In Ah Kim
Journal:  Strahlenther Onkol       Date:  2016-05-25       Impact factor: 3.621

2.  A prospective study on neurocognitive effects after primary radiotherapy in high-grade glioma patients.

Authors:  Raphael Bodensohn; Stefanie Corradini; Ute Ganswindt; Jan Hofmaier; Oliver Schnell; Claus Belka; Maximilian Niyazi
Journal:  Int J Clin Oncol       Date:  2015-12-22       Impact factor: 3.402

3.  Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.

Authors:  S Adeberg; S B Harrabi; N Bougatf; D Bernhardt; J Rieber; S A Koerber; M Syed; T Sprave; A Mohr; A Abdollahi; T Haberer; S E Combs; K Herfarth; J Debus; S Rieken
Journal:  Strahlenther Onkol       Date:  2016-06-22       Impact factor: 3.621

4.  Dosimetric evaluation of intensity-modulated radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for hippocampal-avoidance whole brain radiotherapy.

Authors:  Yi Rong; Josh Evans; Meng Xu-Welliver; Cadron Pickett; Guang Jia; Quan Chen; Li Zuo
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

5.  Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.

Authors:  Ping-Fang Tsai; Chi-Cheng Yang; Chi-Cheng Chuang; Ting-Yi Huang; Yi-Ming Wu; Ping-Ching Pai; Chen-Kan Tseng; Tung-Ho Wu; Yi-Liang Shen; Shinn-Yn Lin
Journal:  Radiat Oncol       Date:  2015-12-10       Impact factor: 3.481

Review 6.  Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.

Authors:  Frederic Dhermain
Journal:  Chin J Cancer       Date:  2014-01

7.  Comparison of dose distributions hippocampus in high grade gliomas irradiation with linac-based imrt and volumetric arc therapy: a dosimetric study.

Authors:  Emine Canyilmaz; Gonca Dilek Hanedan Uslu; Fatma Colak; Burcin Hazeral; Emel Haciislamoglu; Ahmet Yasar Zengin; Ahmet Sari; Adnan Yoney
Journal:  Springerplus       Date:  2015-03-05

8.  Hippocampus-sparing radiotherapy using volumetric modulated arc therapy (VMAT) to the primary brain tumor: the result of dosimetric study and neurocognitive function assessment.

Authors:  Kyung Su Kim; Chan Woo Wee; Jin-Yong Seok; Joo Wan Hong; Jin-Beom Chung; Keun-Yong Eom; Jae-Sung Kim; Chae-Yong Kim; Young Ho Park; Yu Jung Kim; In Ah Kim
Journal:  Radiat Oncol       Date:  2018-02-20       Impact factor: 3.481

Review 9.  Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy.

Authors:  Tomas Kazda; Radim Jancalek; Petr Pospisil; Ondrej Sevela; Tomas Prochazka; Miroslav Vrzal; Petr Burkon; Marek Slavik; Ludmila Hynkova; Pavel Slampa; Nadia N Laack
Journal:  Radiat Oncol       Date:  2014-06-16       Impact factor: 3.481

10.  Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis.

Authors:  Chan Woo Wee; Kyung Su Kim; Chae-Yong Kim; Jung Ho Han; Yu Jung Kim; In Ah Kim
Journal:  Radiat Oncol       Date:  2020-05-06       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.